Form 8-K - Current report:
SEC Accession No. 0001753926-25-000962
Filing Date
2025-06-16
Accepted
2025-06-16 16:25:47
Documents
12
Period of Report
2025-06-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K g084846_8k.htm   iXBRL 8-K 35348
  Complete submission text file 0001753926-25-000962.txt   202760

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lipo-20250616.xsd EX-101.SCH 3011
3 XBRL LABEL FILE lipo-20250616_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE lipo-20250616_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT g084846_8k_htm.xml XML 3849
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 251050465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)